Thyroid Hormone Supplementation in Patients With Septic Shock

PHASE2CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

August 1, 2023

Study Completion Date

August 1, 2023

Conditions
Euthyroid Sick SyndromesSeptic Shock
Interventions
DRUG

triiodothyronine

Patients in septic shock who meet the diagnostic criteria for euthyroid sick syndrome will be divided into two groups; patients with low T3 levels and patients with low T3 and T4 levels. Both of these groups will be further randomly divided into patients receiving T3 hormone and patients receiving placebo.

Trial Locations (1)

72000

Cantonal Hospital, Zenica

All Listed Sponsors
lead

Cantonal Hospital Zenica

OTHER